Pros and cons of product familiarisation programs
Controversy continues to surround product familiarisation programs, with some experts calling for stricter controls.
The programs are run by drug companies and give prescribers an opportunity to use a newly approved medicine while a PBS listing is pending.
Companies must adhere to a strict code of conduct, but opponents argue that patients are being treated as guinea pigs.
Here are just some of the pros and cons of product familiarisation programs:
- Treatment is free for the patient.